Polley Dailey from Kentucky recently filed her Invokana product liability and personal injury claim in the U.S. District Court for the District of New Jersey.
Dailey alleges that she began taking Invokana in 2014, for her type 2 diabetes and within a year, Dailey had to undergo devastating surgery to amputate her right leg because of Invokana side effects.
According to Dailey, Johnson & Johnson and its Janssen Pharmaceuticals subsidiary knew or should have known about that potential amputation side effects of Invokana, but withheld and hid information about the severity of the risks.
What is Invokana?
Invokana (canagliflozin) was released in March 2013, is a new class of diabetes drugs, known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. SGLT2 drugs work by affecting normal kidney functions to increase the release of sugar or glucose into the urine. SGLT2 class of drugs includes Invokamet, Jardiance, Farxiga, Xigduo and others, but Invokana the leader of the pack with blockbuster sales.
Over the last few years many diabetic patients have switched to Invokana, from other diabetic medications such as Avandia (linked to cardiovascular side effects) and Actos (linked to bladder cancer).
Now serious Invokana side effects have been discovered including Invokana amputation risks, diabetic ketoacidosis, kidney failure, heart attacks and other catastrophic injuries.
FDA Invokana Diabetic Ketoacidosis Injury and Warnings
In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana, highlighting that the medication significantly increases the risk of this potentially deadly condition.
Patients were advised by the FDA to stop taking Invokana and seek medical attention immediately if they have any symptoms of ketoacidosis, a serious condition in which the body produces high levels of blood acids called ketones. The FDA warning included data about severe urinary tract infections from Invokana use.
In June 2016, the FDA required additional label warnings about the link between Invokana and kidney risks, highlighting that the medication may increase the risk of acute kidney injury.
Invokana doubles Amputation risk according to studies
Based on new data from two large clinical trials, the FDA in May 2017 concluded that the type 2 diabetes medicines Invokana, Invokamet, Invokamet XR caused an increased risk of leg and foot amputations.
The FDA is requiring new warnings, including their most prominent Boxed Warning, to be added to the Invokana drug labels to describe this risk.
Invokana Federal Multidistrict Litigation
Since December 2016, all federally-filed Invokana injury lawsuits have been consolidated as part of the federal Invokana multidistrict litigation (MDL), which is centralized before U.S. District Judge Brian Martinotti in the District of New Jersey to coordinate discovery and pretrial proceedings.
If you or someone you know succumbed to an Invokana Ketoacidosis, leg amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes, please call us for further information at 888-210-9693. Dr. Shezad Malik Law Firm is investigating Invokana Ketoacidosis, leg amputations or kidney failure from taking Invokana for the treatment of their type 2 diabetes.
Shezad Malik is an Internal Medicine and Cardiology specialist, a Texas Medical Doctor (retired) and Defective Medical Device and Dangerous Drug Attorney. Dr. Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others.